<html>
<head>
<title>Utah Legislature HB0240</title>
</head>
<body>
<div id="content">
<font face="Arial">
</font><font face="Arial" size="3">1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center><b>OPIATE OVERDOSE RESPONSE ACT -- STANDING</b></center><br/>2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><center>ORDERS AND OTHER AMENDMENTS</b></font><font face="Arial" size="2"></center><br/>3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center>2016 GENERAL SESSION</center><br/>4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center>STATE OF UTAH</center><br/>5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center></font><font face="Arial" size="3"><b>Chief Sponsor:  Steve Eliason</b></font><font face="Arial" size="2"></center><br/>6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center></font><font face="Arial" size="3">Senate Sponsor: </font><font face="Arial" size="2"></font><font face="Arial" size="3">  Evan J. Vickers</font><font face="Arial" size="2"></center><br/>7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <hr style="width:90%; padding: 0; border: none; border-top: thick double #333; color: #333; text-align: right" /><br/>8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>LONG TITLE</b><br/>9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>General Description:</b><br/>10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This bill renames the Emergency Administration of Opiate Antagonist Act as the<br/>11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Opiate Overdose Response Act, amends the act, and makes related amendments.<br/>12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Highlighted Provisions:</b><br/>13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This bill:<br/>14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;renames the Emergency Administration of Opiate Antagonist Act as the Opiate<br/>15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Overdose Response Act;<br/>16&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;amends definitions;<br/>17&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;authorizes the use of a standing prescription drug order issued by a physician to<br/>18&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;dispense an opioid antagonist; and<br/>19&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;makes technical and clarifying changes.<br/>20&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Money Appropriated in this Bill:</b><br/>21&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None<br/>22&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Other Special Clauses:</b><br/>23&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None<br/>24&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Utah Code Sections Affected:</b><br/>25&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;AMENDS:<br/>26&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#26-55-101">26-55-101</a></b>, as enacted by Laws of Utah 2014, Chapter 130<br/>27&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#26-55-102">26-55-102</a></b>, as enacted by Laws of Utah 2014, Chapter 130<br/><hr>28&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#26-55-104">26-55-104</a></b>, as enacted by Laws of Utah 2014, Chapter 130<br/>29&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#58-17b-507">58-17b-507</a></b>, as enacted by Laws of Utah 2014, Chapter 130<br/>30&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#58-31b-703">58-31b-703</a></b>, as enacted by Laws of Utah 2014, Chapter 130<br/>31&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#58-67-702">58-67-702</a></b>, as enacted by Laws of Utah 2014, Chapter 130<br/>32&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#58-68-702">58-68-702</a></b>, as enacted by Laws of Utah 2014, Chapter 130<br/>33&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#58-70a-505">58-70a-505</a></b>, as enacted by Laws of Utah 2014, Chapter 130<br/>34&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ENACTS:<br/>35&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#26-55-105">26-55-105</a></b>, Utah Code Annotated 1953<br/>36&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <hr style="width:90%; padding: 0; border: none; border-top: thick double #333; color: #333; text-align: right" /><br/>37&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<i>Be it enacted by the Legislature of the state of Utah:</i><br/>38&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 1.  Section <b>26-55-101</b><a name="26-55-101"></a> is amended to read:<br/>39&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center><b>CHAPTER 55.  OPIATE OVERDOSE RESPONSE ACT</b></center><br/>40&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>26-55-101.</b>   <b>Title.</b><br/>41&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This chapter is known as the "[<strike>Emergency Administration of</strike>] Opiate [<strike>Antagonist</strike>]<br/>42&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Overdose Response</u> Act."<br/>43&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 2.  Section <b>26-55-102</b><a name="26-55-102"></a> is amended to read:<br/>44&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>26-55-102.</b>   <b>Definitions.</b><br/>45&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As used in this chapter:<br/>46&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(1)  "Controlled substance" means the same as that term is defined in Title 58, Chapter</u><br/>47&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>37, Utah Controlled Substances Act.</u><br/>48&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(2)  "Dispense" means the same as that term is defined in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-17b-102&session=2016GS">58-17b-102</a>.</u><br/>49&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(1)</strike>] <u>(3)</u>  "Health care facility" means a hospital, a hospice inpatient residence, a<br/>50&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;nursing facility, a dialysis treatment facility, an assisted living residence, an entity that provides<br/>51&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;home- and community-based services, a hospice or home health care agency, or another facility<br/>52&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;that provides or contracts to provide health care services, which facility is licensed under<br/>53&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chapter 21, Health Care Facility Licensing and Inspection Act.<br/>54&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(2)</strike>] <u>(4)</u>  "Health care provider" means:<br/>55&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)  a physician<u>,</u> as defined in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-67-102&session=2016GS">58-67-102</a>;<br/>56&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)  an advanced practice registered nurse<u>,</u> as defined in Subsection <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-31b-102&session=2016GS">58-31b-102</a>(13); or<br/>57&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)  a physician assistant<u>,</u> as defined in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-70a-102&session=2016GS">58-70a-102</a>.<br/>58&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(5)  "Increased risk" means risk exceeding the risk typically experienced by an</u><br/><hr>59&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>individual who is not using, and is not likely to use, an opiate.</u><br/>60&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(3)</strike>] <u>(6)</u>  "Opiate" [<strike>is</strike>] <u>means the same</u> as <u>that term is</u> defined in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-37-2&session=2016GS">58-37-2</a>.<br/>61&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(4)</strike>] <u>(7)</u>  "Opiate antagonist" means naloxone hydrochloride or any similarly acting<br/>62&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;drug that is not a controlled substance and that is approved by the federal Food and Drug<br/>63&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Administration for the treatment of [<strike>a</strike>] <u>an opiate-related</u> drug overdose.<br/>64&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(5)</strike>] <u>(8)</u>  "Opiate-related drug overdose event" means an acute condition, including a<br/>65&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;decreased level of consciousness or respiratory depression resulting from the consumption or<br/>66&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;use of a controlled substance, or another substance with which a controlled substance was<br/>67&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;combined, and that a person would reasonably believe to require medical assistance.<br/>68&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(9)  "Prescribe" means the same as that term is defined in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-17b-102&session=2016GS">58-17b-102</a>.</u><br/>69&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 3.  Section <b>26-55-104</b><a name="26-55-104"></a> is amended to read:<br/>70&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>26-55-104.</b>   <b>Prescribing, dispensing, and administering an opiate antagonist --</b><br/>71&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Immunity from liability.</b><br/>72&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) (a)  Except as provided in Subsection (1)(b), a person other than a health care<br/>73&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;facility or health care provider who acts in good faith to administer an opiate antagonist to<br/>74&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>another person</strike>] <u>an individual</u> whom the person believes to be [<strike>suffering</strike>] <u>experiencing</u> an<br/>75&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;opiate-related drug overdose event is not liable for any civil damages or acts or omissions made<br/>76&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;as a result of administering the opiate antagonist.<br/>77&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)  A health care provider:<br/>78&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)  does not have immunity from liability under Subsection (1)(a) when the health care<br/>79&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;provider is acting within the scope of the health care provider's responsibilities or duty of care;<br/>80&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and<br/>81&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  does have immunity from liability under Subsection (1)(a) if the health care<br/>82&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;provider is under no legal duty to respond and otherwise complies with Subsection (1)(a).<br/>83&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)  Notwithstanding Sections <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-1-501&session=2016GS">58-1-501</a>, <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-17b-501&session=2016GS">58-17b-501</a>, and <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-17b-502&session=2016GS">58-17b-502</a>, a health care<br/>84&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;provider who is licensed to prescribe [<strike>or dispense</strike>] an opiate antagonist may[<strike>, without a</strike><br/>85&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>prescriber-patient relationship,</strike>] prescribe<u>, including by a standing prescription drug order</u><br/>86&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>issued in accordance with Subsection <a href="#26-55-105">26-55-105</a>(2),</u> or dispense an opiate antagonist [<strike>without</strike><br/>87&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>liability for any civil damages or acts or omissions made as a result of prescribing or dispensing</strike><br/>88&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>an opiate antagonist in good faith, to</strike>]:<br/>89&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <u>(i)  to</u> an individual who is at increased risk of experiencing [<strike>or who is likely to</strike><br/><hr>90&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>experience</strike>] an opiate-related drug overdose event; or<br/>91&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(b)</strike>] <u>(ii)  to</u> a family member of, friend of, or other [<strike>person</strike>] <u>individual</u> who may be in a<br/>92&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;position to assist an individual who [<strike>may be</strike>] <u>is</u> at increased risk of experiencing [<strike>or who is</strike><br/>93&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>likely to experience</strike>] an opiate-related drug overdose event[<strike>.</strike>]<u>;</u><br/>94&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  without a prescriber-patient relationship; and</u><br/>95&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(c)  without liability for any civil damages or acts or omissions made as a result of</u><br/>96&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>prescribing or dispensing the opiate antagonist in good faith.</u><br/>97&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)  A [<strike>person</strike>] <u>health care provider</u> who [<strike>prescribes or</strike>] dispenses an opiate antagonist<br/>98&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>to an individual under Subsection (2)(a) or (2)(b)</u> shall provide education to the individual<br/>99&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>described in Subsection (2)(a) or (b)</strike>] that includes [<strike>instructions to take the person who</strike><br/>100&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>received</strike>] <u>instruction:</u><br/>101&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  on the proper administration of the opiate antagonist; and</u><br/>102&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  that the individual to whom the opiate antagonist is dispensed should ensure that</u><br/>103&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>the individual to whom</u> the opiate antagonist <u>is administered is taken</u> to an emergency care<br/>104&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;facility for a medical evaluation <u>immediately following administration of the opiate antagonist</u>.<br/>105&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 4.  Section <b>26-55-105</b><a name="26-55-105"></a> is enacted to read:<br/>106&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;26-55-105.</u></b>  <b>Standing prescription drug orders for an opiate antagonist.</b><br/>107&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(1)  Notwithstanding Title 58, Chapter 17b, Pharmacy Practice Act, a person licensed</u><br/>108&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>under Title 58, Chapter 17b, Pharmacy Practice Act, to dispense an opiate antagonist may</u><br/>109&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>dispense the opiate antagonist:</u><br/>110&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  pursuant to a standing prescription drug order made in accordance with Subsection</u><br/>111&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(2); and</u><br/>112&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  without any other prescription drug order from a person licensed to prescribe an</u><br/>113&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>opiate antagonist.</u><br/>114&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(2)  A physician who is licensed to prescribe an opiate antagonist may issue a standing</u><br/>115&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>prescription drug order authorizing the dispensing of the opiate antagonist under Subsection (1)</u><br/>116&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>in accordance with a protocol that:</u><br/>117&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  limits dispensing of the opiate antagonist to:</u><br/>118&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(i)  an individual who is at increased risk of experiencing an opiate-related drug</u><br/>119&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>overdose event; or</u><br/>120&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(ii)  a family member of, friend of, or other individual who may be in a position to</u><br/><hr>121&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>assist an individual who is at increased risk of experiencing an opiate-related drug overdose</u><br/>122&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>event;</u><br/>123&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  requires the physician to specify the persons, by professional license number,</u><br/>124&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>authorized to dispense the opiate antagonist;</u><br/>125&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(c)  requires the physician to review at least annually the dispensing practices of those</u><br/>126&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>authorized by the physician to dispense the opiate antagonist;</u><br/>127&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(d)  requires those authorized by the physician to dispense the opiate antagonist to make</u><br/>128&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>and retain a record of each individual to whom the opiate antagonist is dispensed, which shall</u><br/>129&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>include:</u><br/>130&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(i)  the name of the individual;</u><br/>131&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(ii)  the drug dispensed; and</u><br/>132&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(iii)  other relevant information; and</u><br/>133&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(e)  is approved by the Division of Occupational and Professional Licensing within the</u><br/>134&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Department of Commerce by administrative rule made in accordance with Title 63G, Chapter</u><br/>135&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>3, Utah Administrative Rulemaking Act.</u><br/>136&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 5.  Section <b>58-17b-507</b><a name="58-17b-507"></a> is amended to read:<br/>137&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>58-17b-507.</b>   <b>Opiate antagonist -- Immunity from liability -- Exclusion from</b><br/>138&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>unlawful or unprofessional conduct.</b><br/>139&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)  <u>As used in this section:</u><br/>140&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  "Opiate antagonist" means the same as that term is defined in Section <a href="#26-55-102">26-55-102</a>.</u><br/>141&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  "Opiate-related drug overdose event" means the same as that term is defined in</u><br/>142&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Section <a href="#26-55-102">26-55-102</a>.</u><br/>143&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(2)</u>  A person licensed under this chapter who dispenses an opiate antagonist [<strike>as defined</strike><br/>144&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>in Section <a href="#26-55-102">26-55-102</a></strike>] to an individual with a prescription for an opiate antagonist<u>, or pursuant</u><br/>145&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>to a standing prescription drug order issued in accordance with Subsection <a href="#26-55-105">26-55-105</a>(2),</u> is not<br/>146&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;liable for any civil damages resulting from the outcomes that result from the eventual<br/>147&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;administration of the opiate antagonist to [<strike>a person</strike>] <u>an individual</u> who another [<strike>person</strike>]<br/>148&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>individual</u> believes is [<strike>suffering</strike>] <u>experiencing</u> an opiate-related drug overdose [<strike>as defined in</strike><br/>149&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>Section <a href="#26-55-102">26-55-102</a></strike>] <u>event</u>.<br/>150&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(2)</strike>] <u>(3)</u>  The provisions of this section <u>and Title 26, Chapter 55, Opiate Overdose</u><br/>151&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Response Act,</u> do not establish a duty or standard of care in the prescribing, dispensing, or<br/><hr>152&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;administration of an opiate antagonist.<br/>153&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(3)</strike>] <u>(4)</u>  It is not unprofessional conduct or unlawful conduct for a licensee under this<br/>154&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;chapter to dispense an opiate antagonist to [<strike>a person</strike>] <u>an individual</u> on behalf of another<br/>155&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>person</strike>] <u>individual</u> if the [<strike>person</strike>] <u>individual</u> obtaining the opiate antagonist has a prescription<br/>156&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;for the opiate antagonist from a licensed prescriber <u>or the opiate antagonist is dispensed</u><br/>157&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>pursuant to a standing prescription drug order issued in accordance with Subsection</u><br/>158&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u><a href="#26-55-105">26-55-105</a>(2)</u>.<br/>159&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 6.  Section <b>58-31b-703</b><a name="58-31b-703"></a> is amended to read:<br/>160&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>58-31b-703.</b>   <b>Opiate antagonist -- Exclusion from unprofessional or unlawful</b><br/>161&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>conduct.</b><br/>162&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(1)  Title 26, Chapter 55, Emergency Administration of Opiate Antagonist Act, applies</strike><br/>163&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>to a licensee under this chapter.</strike>]<br/>164&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(1)  As used in this section:</u><br/>165&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  "Dispensing" means the same as that term is defined in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-17b-102&session=2016GS">58-17b-102</a>.</u><br/>166&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  "Increased risk" means the same as that term is defined in Section <a href="#26-55-102">26-55-102</a>.</u><br/>167&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(c)  "Opiate antagonist" means the same as that term is defined in Section <a href="#26-55-102">26-55-102</a>.</u><br/>168&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(d)  "Opiate-related drug overdose event" means the same as that term is defined in</u><br/>169&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=26-155-102&session=2016GS">26-155-102</a>.</u><br/>170&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(e)  "Prescribing" means the same as that term is defined in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-17b-102&session=2016GS">58-17b-102</a>.</u><br/>171&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)  The prescribing or dispensing of an opiate antagonist [<strike>as defined in Section</strike><br/>172&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike><a href="#26-55-102">26-55-102</a></strike>] by a licensee under this chapter is not unprofessional or unlawful conduct if the<br/>173&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;licensee prescribed or dispensed the opiate antagonist in a good faith effort to assist:<br/>174&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)  [<strike>a person</strike>] <u>an individual</u> who is at increased risk of experiencing [<strike>or who is likely to</strike><br/>175&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>experience</strike>] an opiate-related drug overdose event [<strike>as defined in Section <a href="#26-55-102">26-55-102</a></strike>]; or<br/>176&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)  a family member of, friend of, or other [<strike>person</strike>] <u>individual</u> who is in a position to<br/>177&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;assist [<strike>a person</strike>] <u>an individual</u> who [<strike>may be</strike>] <u>is</u> at increased risk of experiencing [<strike>or who is</strike><br/>178&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>likely to experience</strike>] an opiate-related drug overdose event.<br/>179&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)  The provisions of this section and Title 26, Chapter 55, [<strike>Emergency Administration</strike><br/>180&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>of</strike>] Opiate [<strike>Antagonist</strike>] <u>Overdose Response</u> Act, do not establish a duty or standard of care in<br/>181&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the prescribing, dispensing, or administration of an opiate antagonist.<br/>182&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 7.  Section <b>58-67-702</b><a name="58-67-702"></a> is amended to read:<br/><hr>183&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>58-67-702.</b>   <b>Opiate antagonist -- Exclusion from unlawful or unprofessional</b><br/>184&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>conduct.</b><br/>185&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(1)  Title 26, Chapter 55, Emergency Administration of Opiate Antagonist Act, applies</strike><br/>186&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>to a licensee under this chapter.</strike>]<br/>187&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(1)  As used in this section:</u><br/>188&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  "Dispensing" means the same as that term is defined in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-17b-102&session=2016GS">58-17b-102</a>.</u><br/>189&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  "Increased risk" means the same as that term is defined in Section <a href="#26-55-102">26-55-102</a>.</u><br/>190&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(c)  "Opiate antagonist" means the same as that term is defined in Section <a href="#26-55-102">26-55-102</a>.</u><br/>191&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(d)  "Opiate-related drug overdose event" means the same as that term is defined in</u><br/>192&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Section <a href="#26-55-102">26-55-102</a>.</u><br/>193&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(e)  "Prescribing" means the same as that term is defined in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-17b-102&session=2016GS">58-17b-102</a>.</u><br/>194&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)  The prescribing or dispensing of an opiate antagonist [<strike>as defined in Section</strike><br/>195&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike><a href="#26-55-102">26-55-102</a></strike>] by a licensee under this chapter is not unprofessional or unlawful conduct if the<br/>196&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;licensee prescribed or dispensed the opiate antagonist in a good faith effort to assist:<br/>197&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)  [<strike>a person</strike>] <u>an individual</u> who is at increased risk of experiencing [<strike>or who is likely to</strike><br/>198&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>experience</strike>] an opiate-related drug overdose event [<strike>as defined in Section <a href="#26-55-102">26-55-102</a></strike>]; or<br/>199&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)  a family member of, friend of, or other [<strike>person</strike>] <u>individual</u> who is in a position to<br/>200&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;assist [<strike>a person</strike>] <u>an individual</u> who [<strike>may be</strike>] <u>is</u> at increased risk of experiencing [<strike>or who is</strike><br/>201&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>likely to experience</strike>] an opiate-related drug overdose event.<br/>202&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)  The provisions of this section and Title 26, Chapter 55, [<strike>Emergency Administration</strike><br/>203&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>of</strike>] Opiate [<strike>Antagonist</strike>] <u>Overdose Response</u> Act, do not establish a duty or standard of care in<br/>204&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the prescribing, dispensing, or administration of an opiate antagonist.<br/>205&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 8.  Section <b>58-68-702</b><a name="58-68-702"></a> is amended to read:<br/>206&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>58-68-702.</b>   <b>Opiate antagonist -- Exclusion from unlawful or unprofessional</b><br/>207&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>conduct.</b><br/>208&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(1)  Title 26, Chapter 55, Emergency Administration of Opiate Antagonist Act, applies</strike><br/>209&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>to a licensee under this chapter.</strike>]<br/>210&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(1)  As used in this section:</u><br/>211&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  "Dispensing" means the same as that term is defined in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-17b-102&session=2016GS">58-17b-102</a>.</u><br/>212&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  "Increased risk" means the same as that term is defined in Section <a href="#26-55-102">26-55-102</a>.</u><br/>213&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(c)  "Opiate antagonist" means the same as that term is defined in Section <a href="#26-55-102">26-55-102</a>.</u><br/><hr>214&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(d)  "Opiate-related drug overdose event" means the same as that term is defined in</u><br/>215&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Section <a href="#26-55-102">26-55-102</a>.</u><br/>216&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(e)  "Prescribing" means the same as that term is defined in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-17b-102&session=2016GS">58-17b-102</a>.</u><br/>217&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)  The prescribing or dispensing of an opiate antagonist [<strike>as defined in Section</strike><br/>218&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike><a href="#26-55-102">26-55-102</a></strike>] by a licensee under this chapter is not unprofessional or unlawful conduct if the<br/>219&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;licensee prescribed or dispensed the opiate antagonist in a good faith effort to assist:<br/>220&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)  [<strike>a person</strike>] <u>an individual</u> who is at increased risk of experiencing [<strike>or who is likely to</strike><br/>221&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>experience</strike>] an opiate-related drug overdose event [<strike>as defined in Section <a href="#26-55-102">26-55-102</a></strike>]; or<br/>222&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)  a family member of, friend of, or other [<strike>person</strike>] <u>individual</u> who is in a position to<br/>223&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;assist [<strike>a person</strike>] <u>an individual</u> who [<strike>may be</strike>] <u>is</u> at increased risk of experiencing [<strike>or who is</strike><br/>224&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>likely to experience</strike>] an opiate-related drug overdose event.<br/>225&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)  The provisions of this section and Title 26, Chapter 55, [<strike>Emergency Administration</strike><br/>226&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>of</strike>] Opiate [<strike>Antagonist</strike>] <u>Overdose Response</u> Act, do not establish a duty or standard of care in<br/>227&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the prescribing, dispensing, or administration of an opiate antagonist.<br/>228&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 9.  Section <b>58-70a-505</b><a name="58-70a-505"></a> is amended to read:<br/>229&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>58-70a-505.</b>   <b>Opiate antagonist -- Exclusion from unlawful or unprofessional</b><br/>230&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>conduct.</b><br/>231&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(1)  Title 26, Chapter 55, Emergency Administration of Opiate Antagonist Act, applies</strike><br/>232&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>to a licensee under this chapter.</strike>]<br/>233&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(1)  As used in this section:</u><br/>234&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  "Dispensing" means the same as that term is defined in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-17b-102&session=2016GS">58-17b-102</a>.</u><br/>235&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  "Increased risk" means the same as that term is defined in Section <a href="#26-55-102">26-55-102</a>.</u><br/>236&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(c)  "Opiate antagonist" means the same as that term is defined in Section <a href="#26-55-102">26-55-102</a>.</u><br/>237&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(d)  "Opiate-related drug overdose event" means the same as that term is defined in</u><br/>238&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Section <a href="#26-55-102">26-55-102</a>.</u><br/>239&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(e)  "Prescribing" means the same as that term is defined in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-17b-102&session=2016GS">58-17b-102</a>.</u><br/>240&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)  The prescribing or dispensing of an opiate antagonist [<strike>as defined in Section</strike><br/>241&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike><a href="#26-55-102">26-55-102</a></strike>] by a licensee under this chapter is not unprofessional or unlawful conduct if the<br/>242&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;licensee prescribed or dispensed the opiate antagonist in a good faith effort to assist:<br/>243&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)  [<strike>a person</strike>] <u>an individual</u> who is at increased risk of experiencing [<strike>or who is likely to</strike><br/>244&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>experience</strike>] an opiate-related drug overdose event [<strike>as defined in Section <a href="#26-55-102">26-55-102</a></strike>]; or<br/><hr>245&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)  a family member of, friend of, or other [<strike>person</strike>] <u>individual</u> who is in a position to<br/>246&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;assist [<strike>a person</strike>] <u>an individual</u> who [<strike>may be</strike>] <u>is</u> at increased risk of experiencing [<strike>or who is</strike><br/>247&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>likely to experience</strike>] an opiate-related drug overdose event.<br/>248&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)  The provisions of this section and Title 26, Chapter 55, [<strike>Emergency Administration</strike><br/>249&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>of</strike>] Opiate [<strike>Antagonist</strike>] <u>Overdose Response</u> Act, do not establish a duty or standard of care in<br/>250&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the prescribing, dispensing, or administration of an opiate antagonist.<br/><br/><hr style="width:90%; color: #333; text-align: right" /><br/><hr style="width:90%; color: #333; text-align: right" /><br/><br/><b>Legislative Review Note<br/>Office of Legislative Research and General Counsel</b>
</font>
</div>
</body>
</html>
